Clinical Trials Browser

Withdrawn × Prostatic Neoplasms × sargramostim × Clear all

NCT01530984 2015-10-05

Ipilimumab and GMCSF Immunotherapy for Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms